Inhibitor of H3K27 demethylase JMJD3/UTX GSK-J4 is a...

Oncotarget 2017 / 09 Vol. 8; Iss. 37

Inhibitor of H3K27 demethylase JMJD3/UTX GSK-J4 is a potential therapeutic option for castration resistant prostate cancer

Morozov, Viacheslav M., Li, Ying, Clowers, Matthew M., Ishov, Alexander M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Language:
english
Journal:
Oncotarget
DOI:
10.18632/oncotarget.19100
Date:
September, 2017
File:
PDF, 4.22 MB
english, 2017
Conversion to is in progress
Conversion to is failed